MR1 and Hepatic fibrosis: Combining human data in ex vivo precision-cut liver slices with mouse models and cell culture experiments, the present study demonstrates that inhibiting MAIT cell activation by MR1 inhibitory ligands constitutes an interesting strategy to limit liver fibrosis progression and promote fibrosis resolution.